Ocrevus Zunovo ocrelizumab 920 mg and hyaluronidase-ocsq 23,000 units /23 mL Images
Generic Name: hyaluronidase/ocrelizumab
This medication has been identified as Ocrevus Zunovo ocrelizumab 920 mg and hyaluronidase-ocsq 23,000 units /23 mL. It is supplied by Genentech, Inc.
Ocrevus Zunovo is used in the treatment of Multiple Sclerosis and belongs to the drug class CD20 monoclonal antibodies. Ocrevus Zunovo ocrelizumab 920 mg and hyaluronidase-ocsq 23,000 units /23 mL is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Ocrevus Zunovo
- Generic Name
- hyaluronidase/ocrelizumab
- Strength
- ocrelizumab 920 mg and hyaluronidase-ocsq 23,000 units /23 mL
- Availability
- Prescription only
- Drug Class
- CD20 monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0554
See also:
Ocrevus
Ocrevus (ocrelizumab) is used for MS to treat relapsing and primary progressive forms of multiple ...
Tecfidera
Tecfidera (dimethyl fumarate) is used to treat relapsing forms of multiple sclerosis. Learn about ...
Avonex
Avonex is an interferon used to treat relapsing multiple sclerosis. It is given by injection into a ...
Briumvi
Briumvi is used to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically ...
Betaseron
Betaseron is used to treat relapsing multiple sclerosis (MS). Learn about side effects ...
Rebif
Rebif is used to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically ...
Extavia
Extavia is used to treat the relapsing forms of multiple sclerosis. Learn about side effects ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Copaxone
Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including ...
More about Ocrevus Zunovo (hyaluronidase / ocrelizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.